<DOC>
	<DOCNO>NCT02184351</DOCNO>
	<brief_summary>The objective study compare efficacy safety Roxane 's clotrimazole troche vs. Mycelex troche HIV positive patient oropharyngeal candidiasis , condition diagnose clinical examination confirm fungal culture .</brief_summary>
	<brief_title>Clotrimazole vs. Mycelex® Patients With Human Insufficiency Virus ( HIV ) Infection Treatment Oropharyngeal Candidiasis</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Oral</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Clotrimazole</mesh_term>
	<criteria>Documented HIV positive status Clinical examination oropharynx consistent diagnosis oral Candidiasis ( creamy , white , curdlike patch erythematous lesion mucosal surface ) Findings direct microscopic examination ( Gram Stain potassium hydroxide smear ) consistent Candida specie positive fungal culture Candida specie , culture obtain 2 day precede initiation therapy study drug Male female patient ≥ 18 year For woman childbearing potential : negative blood urine pregnancy test agreement use adequate contraception ( investigator 's discretion ) study drug Mental status allow comprehension instruction troche administration Written inform consent Sings symptom suggestive esophageal Candidiasis ( dysphagia odynophagia ) unless result endoscopic evaluation esophagus negative Presence perioral lesion Use antifungal agent within 5 day enrollment study Pregnant lactate woman History hypersensitivity imidazole azole compound Patient unwilling unable follow study center duration study ( 3 week ) Patients receive investigational drug last 30 day Treatment another investigational drug plan within next 3 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>